Bausch Health Companies Inc. Deferred Tax Liabilities, Net, Current
Bausch Health Companies Inc. (BHC) had Deferred Tax Liabilities, Net, Current of $0 as of 2015-12-31, per its 10-K filed 2016-04-29.
Discontinued › Notes › Income Taxes
us-gaap:DeferredTaxLiabilitiesCurrent · last filed 2016-04-29
- 2015-12-31: Deferred Tax Liabilities, Net, Current $0.00.
- 2015-09-30: Deferred Tax Liabilities, Net, Current $11.60M.
- 2015-06-30: Deferred Tax Liabilities, Net, Current $38.20M.
- 2015-03-31: Deferred Tax Liabilities, Net, Current $11.10M.
| Period end | Deferred Tax Liabilities, Net, Current | Deferred Tax Liabilities, Net, Current as first filed |
|---|---|---|
| 2015-12-31 | $0.00 10-K · filed 2016-04-29 | |
| 2015-09-30 | $11.60M 10-Q · filed 2015-10-26 | |
| 2015-06-30 | $38.20M 10-Q · filed 2015-07-28 | |
| 2015-03-31 | $11.10M 10-Q · filed 2015-04-30 | |
| 2014-12-31 | $10.70M 10-K · filed 2016-04-29 | |
| 2014-09-30 | $19.00M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $11.00M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $10.80M 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $66.00M 10-K · filed 2015-02-25 | $66.02M 10-K · filed 2014-02-28 |
| 2013-09-30 | $64.19M 10-Q · filed 2013-11-01 | |
| 2013-06-30 | $4.36M 10-Q · filed 2013-08-07 | |
| 2013-03-31 | $4.29M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $4.40M 10-K · filed 2014-02-28 | |
| 2012-09-30 | $8.79M 10-Q · filed 2012-11-05 | |
| 2012-06-30 | $7.53M 10-Q · filed 2012-08-03 | |
| 2012-03-31 | $3.96M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $4.44M 10-K · filed 2013-02-28 | |
| 2011-09-30 | $4.06M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $3.77M 10-Q · filed 2011-08-08 | |
| 2011-03-31 | $1.89M 10-Q · filed 2011-05-10 | |
| 2010-12-31 | $799.00K 10-K · filed 2012-02-29 | |
| 2010-09-30 | $5.69M 10-Q · filed 2010-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |